In this contingency planning guidance, a set of actions to prepare for emergencies from all hazards and to help minimize their impact, is proposed. These actions include the development, implementation, simulation, monitoring and regular update of risks-based contingency plans.
Planning and Implementation Training. Myanmar
This training module on resilient development planning in Myanmar consists of a 2.5 hours session, at the end of which, the participants will:
a) Have a common understanding on development and disaster linkages.
b) Be able to identify the ...various factors which contribute towards disaster risk including climate change in Myanmar.
c) Be able to identify measures for risk resilient development process in Myanmar.
The three main learning units include:
1. Disaster and development linkages.
2. Components and drivers of disaster risk including climate change.
3. Mainstreaming disaster and climate risk reduction into development.
more
Updated May 2017
This document is meant to respond to the questions:
■ What health interventions should be the newborn and young infants < 2 months of age receive and when should s/he receive it?
■ What health behaviours should a mother/caregiver practise (or not practise)?
This document is meant to respond to the questions:
■ What health interventions should the adolescent receive and when should s/he receive it?
■ What health behaviours should the adolescent practise (or not practise)?
Treating the Patient with Tuberculosis
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Accessed November 2, 2017
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...ted. Initially, due to their high prices, affordability of DAAs was limited in high-, middle- and low-
income countries alike. Now there is a divide between those countries where, because of intellectual
property barriers, prices have remained (very) high and other countries where generics are, or can be,
available at much lower prices. The result is a dual market
more